This bill amends the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence (AI) and machine learning technologies to legally prescribe drugs under specific conditions. It requires AI systems to be both authorized by state law and approved by the FDA under sections 510(k), 513, 515, or 564. The law directly affects healthcare AI developers, providers, and patients by establishing a regulatory framework for AI-driven drug prescriptions. Key provisions define AI as a "practitioner" for prescription purposes only when meeting these two federal and state requirements. This creates a clear pathway for AI to legally prescribe drugs within existing FDA and state oversight.
S 1106 establishes a new Immersive Technology Advisory Panel and designates a Principal Advisor on immersive technology to guide U.S. leadership in this field. The panel, composed of federal agency heads (like Defense and Commerce) and external experts, will study how immersive technology - including augmented reality, virtual reality, and mixed reality - affects economic competitiveness, national security, and key sectors like healthcare, education, and manufacturing. Within two years, the panel must complete a study and submit a report to Congress with recommendations on standards, cybersecurity, ethical safeguards, and strategies to maintain U.S. global leadership. The bill directly affects federal agencies and aims to coordinate government-private sector efforts without mandating new regulations or funding.
This bill requires the federal government to assess and address cybersecurity risks from quantum computers that could break current encryption. It mandates a detailed report within one year (and annual updates) evaluating U.S. progress compared to other countries in developing quantum computers and adopting post-quantum cryptography, identifying vulnerable sectors (like finance or critical infrastructure), and creating a mitigation plan. The plan must facilitate government-private sector collaboration, information sharing, and technical assistance to help entities adopt security measures. The bill also directs the creation of guidelines to define "cryptographically-relevant quantum computers" and includes recommendations for implementing the plan through legislation or policy. This directly affects federal agencies, private companies, and public entities handling sensitive data.
The AI Grand Challenges Act of 2026 establishes a National Science Foundation program to award cash prizes for solving specific, measurable AI research challenges across 15 priority areas like national security, health, energy, and cancer breakthroughs. It requires the NSF Director to create prize competitions with minimum $1 million awards per winner (including a mandatory $10 million cancer-focused competition), targeting U.S.-based entities or citizens. Key mechanisms include publishing clear problem statements and success metrics on Challenge.gov, consulting public and federal agencies on challenge selection, and reporting annual results to Congress. The bill directly affects U.S. researchers, companies, and organizations developing AI solutions for federally identified challenges.
HR 6647, the Drone Safety Enhancement Act, requires NASA to collaborate with the FAA and other agencies on research into drone technology and advanced air mobility systems. It mandates NASA to brief Congress within 18 months on progress related to unmanned aircraft systems, traffic management (UTM), and autonomous capabilities. The bill directly affects NASA, the FAA, and industry stakeholders developing urban/regional air mobility systems using drones or autonomous aircraft. It focuses on research coordination rather than imposing new regulations, defining terms like "urban air mobility" (e.g., passenger drones under 1,320 lbs) and "regional air mobility" (e.g., larger cargo drones).
